View all text of Subchapter VIII [§ 381 - § 384g]
§ 384f. Strengthening FDA and CBP coordination and capacity
(a) In general
(b) FDA import facilities and inspection capacity
(1) In generalIn carrying out this section, the Secretary shall, in collaboration with the Secretary of Homeland Security and the Postmaster General of the United States Postal Service, provide that import facilities in which the Food and Drug Administration operates or carries out activities related to drug imports within the international mail facilities include—
(A) facility upgrades and improved capacity in order to increase and improve inspection and detection capabilities, which may include, as the Secretary determines appropriate—
(i) improvements to facilities, such as upgrades or renovations, and support for the maintenance of existing import facilities and sites to improve coordination between Federal agencies;
(ii) improvements in equipment and information technology enhancement to identify unapproved, counterfeit, or other unlawful controlled substances for destruction;
(iii) the construction of, or upgrades to, laboratory capacity for purposes of detection and testing of imported goods;
(iv) upgrades to the security of import facilities; and
(v) innovative technology and equipment to facilitate improved and near-real-time information sharing between the Food and Drug Administration, the Department of Homeland Security, and the United States Postal Service; and
(B) innovative technology, including controlled substance detection and testing equipment and other applicable technology, in order to collaborate with the U.S. Customs and Border Protection to share near-real-time information, including information about test results, as appropriate.
(2) Innovative technology
(c) Report
(Pub. L. 115–271, title III, § 3014, Oct. 24, 2018, 132 Stat. 3937.)